| • | | William Mitchell admitted that, had Mr. Jorgl disclosed those (nonexistent) arrangements or understandings, Mitchell still would have rejected Mr. Jorgl’s nomination letter – confirming he was always going to reject the nominations, regardless of their validity. |
| • | | The members of the ASFV Committee each stated through uncontroverted sworn testimony that they had no undisclosed arrangements or understandings of any kind, including with the four AIM stockholders the Board (erroneously) believed were involved in Mr. Jorgl’s nomination efforts. |
| • | | And each of the four AIM stockholders similarly stated through uncontroverted sworn testimony that they were not involved with Mr. Jorgl’s nomination efforts, much less had “arrangements or understandings” with the ASFV Committee about those nominations. In other words, the incumbent Board’s pretext for denying Mr. Jorgl’s nomination letter has been debunked. |
The ASFV Committee continued:
What has become evident is that the incumbent directors have enriched themselves at the expense of stockholders and patients. They are now panicking that they may lose their board seats (and excessive compensation) in a fair election and are desperately trying to spin any narrative to take the focus off their bad behavior to avoid their expected proxy loss. The preliminary injunction hearing in Delaware was held on October 5th, and the parties are currently awaiting a ruling. The ASFV Committee remains confident that Mr. Jorgl’s nomination was valid. Pending a decision by the court, the stockholders should not be distracted by the false narrative and misleading information disseminated by the incumbent board.
It is time for accountability and much needed change at AIM – the ASFV Committee urges all stockholders to vote on the GOLD proxy card today to elect ONLY Robert L. Chioini and Michael Rice.
It is important that you mark the boxes for Robert L. Chioini and Michael Rice ONLY and leave the boxes for the incumbent AIM directors unmarked.
Contact:
Alliance Advisors, LLC
200 Broadacres Drive, 3rd Floor
Bloomfield, New Jersey 07003
(877) 728-5012
aim@allianceadvisors.com
Important Information and Participants in the Solicitation
The ASFV Committee has filed a definitive proxy statement and associated GOLD proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit votes for the election of its slate of highly-qualified director nominees at the Annual Meeting. Details regarding the ASFV Committee’s nominees are included in the proxy statement.
THE ASFV COMMITTEE STRONGLY ADVISES ALL STOCKHOLDERS OF AIM TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY CONTAIN IMPORTANT INFORMATION.
Information regarding the identity of participants in the ASFV Committee’s solicitation, and their direct or indirect interests, by security holdings or otherwise, is set forth in the ASFV Committee’s proxy statement. Stockholders can obtain a copy of the proxy statement, and any amendments or supplements thereto and other documents filed by the ASFV Committee with the SEC for no charge at the SEC’s website at www.sec.gov. Copies will also be available at no charge at the following website: https://viewproxy.com/aim/. Investors can also contact Alliance Advisors at the telephone number or email address set for the above.
As of the date hereof, Mr. Jorgl is the record and beneficial owner of 1,000 shares of common stock, par value $0.001 per share, of AIM (the “common stock”). As of the date hereof, no other Participant is the record or beneficial owner of any shares of common stock.